Literature DB >> 18851919

Soluble CD40 ligand as a biomarker for storage-related preanalytic variations of human serum.

Juliette Lengellé1, Evangelos Panopoulos, Fotini Betsou.   

Abstract

There are currently no appropriate and sensitive biomarkers available to assess preanalytic variations in human biological fluids stored in biobanks. We identified soluble CD40 ligand (sCD40L) as the first ubiquitous biomarker to show an on-off response in serum exposed to moderate or elevated room temperature conditions. We used immunoenzyme assays to monitor the sCD40L response after 12 h storage at 37 degrees C or 48 h at 20 degrees C. Our findings show that prolonged storage of serum samples at elevated room temperature can be determined by the absence of detectable sCD40L.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18851919     DOI: 10.1016/j.cyto.2008.08.010

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  11 in total

1.  Biobanking and international interoperability: samples.

Authors:  Michael Kiehntopf; Michael Krawczak
Journal:  Hum Genet       Date:  2011-07-15       Impact factor: 4.132

Review 2.  Identification of evidence-based biospecimen quality-control tools: a report of the International Society for Biological and Environmental Repositories (ISBER) Biospecimen Science Working Group.

Authors:  Fotini Betsou; Elaine Gunter; Judith Clements; Yvonne DeSouza; Katrina A B Goddard; Fiorella Guadagni; Wusheng Yan; Amy Skubitz; Stella Somiari; Trina Yeadon; Rodrigo Chuaqui
Journal:  J Mol Diagn       Date:  2012-11-27       Impact factor: 5.568

3.  The effect of hormone therapy and tibolone on serum CD40L and ADAM-8 in healthy post-menopausal women.

Authors:  I Lambrinoudaki; M Karaflou; G Kaparos; O Grigoriou; A Alexandrou; C Panoulis; E Logothetis; M Creatsa; G Christodoulakos; E Kouskouni
Journal:  J Endocrinol Invest       Date:  2010-04-30       Impact factor: 4.256

4.  Clinical biospecimens: reference materials, certified for nominal properties?

Authors:  Fay Betsou
Journal:  Biopreserv Biobank       Date:  2014-04       Impact factor: 2.300

Review 5.  Understanding preanalytical variables and their effects on clinical biomarkers of oncology and immunotherapy.

Authors:  Lokesh Agrawal; Kelly B Engel; Sarah R Greytak; Helen M Moore
Journal:  Semin Cancer Biol       Date:  2017-12-16       Impact factor: 15.707

6.  A Pilot Study of the ELFE Longitudinal Cohort: Feasibility and Preliminary Evaluation of Biological Collection.

Authors:  Amivi Oleko; Fotini Betsou; Hélène Sarter; Claire Gerdil; Isabelle Desbois; Marie Aline Charles; Henri Leridon; Stéphanie Vandentorren
Journal:  Biopreserv Biobank       Date:  2011-09       Impact factor: 2.300

7.  The Infectious Diseases BioBank at King's College London: archiving samples from patients infected with HIV to facilitate translational research.

Authors:  Rachel Williams; Christine Mant; John Cason
Journal:  Retrovirology       Date:  2009-11-03       Impact factor: 4.602

Review 8.  Biobanking for better healthcare.

Authors:  Peter H J Riegman; Manuel M Morente; Fay Betsou; Pasquale de Blasio; Peter Geary
Journal:  Mol Oncol       Date:  2008-07-30       Impact factor: 6.603

9.  Cell surface concentrations and concentration ranges for testing in vitro autocrine loops and small molecules.

Authors:  Nikhil Mittal
Journal:  PLoS One       Date:  2012-12-28       Impact factor: 3.240

Review 10.  Cytokines as biomarkers in rheumatoid arthritis.

Authors:  Agata Burska; Marjorie Boissinot; Frederique Ponchel
Journal:  Mediators Inflamm       Date:  2014-03-09       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.